Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Cash flows from operating activities    
Net loss attributable to common stockholders $ (117,105) $ (56,415)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation, depletion and amortization 15,113 16,290
Loss on early extinguishment of debt 0 507
Amortization of debt issuance and discount costs 2,209 7,165
Non-cash compensation 63,689 2,289
Crest royalty 0 (25,664)
Net loss attributable to non-controlling interest (7,524) (2,438)
Investment in restricted cash and cash equivalents (33,850) (26,830)
Non-cash derivative loss 18,123 171
Other (2,828) (2,805)
Changes in operating assets and liabilities:    
Accounts and interest receivable 953 1,169
Accounts payable and accrued liabilities 49,631 17,516
LNG inventory, net 2,440 3,269
Deferred revenue (2,210) (1,104)
Prepaid expenses and other (1,860) (1,816)
Net cash used in operating activities (13,219) (68,696)
Cash flows from investing activities    
Investment in Cheniere Partners (7,449) (60)
LNG terminal and pipeline costs, net (464,187) (270)
Use of restricted cash and cash equivalents 463,617 784
Other (1,972) (2,499)
Net cash used in investing activities (9,991) (2,045)
Cash flows from financing activities    
Proceeds from sale of common stock, net 0 351,907
Proceeds from 2021 Sabine Pass Liquefaction Notes 1,500,000 0
Proceeds from sale of common units by Cheniere Partners 365,000 2,843
Repurchases and prepayments of debt 0 (298,000)
Use of (investment in) restricted cash and cash equivalents (1,818,313) 5,249
Debt issuance and deferred financing costs (34,986) 0
Distributions to non-controlling interest (11,698) (8,092)
Purchase of treasury shares (460) (1,798)
Other (3) (701)
Net cash provided by (used in) financing activities (460) 51,408
Net decrease in cash and cash equivalents (23,670) (19,333)
Cash and cash equivalents—beginning of period 201,711 459,160
Cash and cash equivalents—end of period $ 178,041 $ 439,827